Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Neonc Technologies, Inc.
St. Jude Children's Research Hospital
AbbVie
The Hospital for Sick Children
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
OHSU Knight Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Societe Internationale d'Oncologie Pediatrique
Children's Oncology Group
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
City of Hope Medical Center
Dana-Farber Cancer Institute
Memorial Sloan Kettering Cancer Center
NYU Langone Health
NYU Langone Health
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Universitätsklinikum Hamburg-Eppendorf
National Cancer Institute (NCI)
University of Pittsburgh
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Children's Oncology Group
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Fox Chase Cancer Center
National Cancer Institute (NCI)
NYU Langone Health
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
City of Hope Medical Center
NYU Langone Health